HEMORRHAGIC COMPLICATIONS OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL-INFARCTION AND VENOUS THROMBOEMBOLISM

被引：31

作者：

LEVINE, MN

GOLDHABER, SZ

CALIFF, RM

GORE, JM

HIRSH, J

机构：

[1] BRIGHAM & WOMENS HOSP,DIV CARDIOVASC,BOSTON,MA 02115

[2] UNIV MASSACHUSETTS,MED CTR,WORCESTER,MA 01605

[3] DUKE UNIV,MED CTR,DIV CARDIOL,DURHAM,NC 27710

[4] HAMILTON CIV HOSP,MED CTR,HAMILTON,ONTARIO,CANADA

来源：

CHEST | 1992年 / 102卷 / 04期

关键词：

D O I：

10.1378/chest.102.4_Supplement.364S

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：S364 / S373

页数：10

共 68 条

[1] MULTICENTER PATENCY TRIAL OF INTRAVENOUS ANISTREPLASE COMPARED WITH STREPTOKINASE IN ACUTE MYOCARDIAL-INFARCTION [J].

ANDERSON, JL ;

SORENSEN, SG ;

MORENO, FL ;

HACKWORTHY, RA ;

BROWNE, KF ;

DALE, HT ;

LEYA, F ;

DANGOISSE, V ;

ECKERSON, HW ;

MARDER, VJ .

CIRCULATION, 1991, 83 (01) :126-140

[2]

[Anonymous], 1990, Lancet, V336, P65

[3]

[Anonymous], 1986, Lancet, V1, P397

[4] TISSUE PLASMINOGEN-ACTIVATOR - TORONTO (TPAT) PLACEBO-CONTROLLED RANDOMIZED TRIAL IN ACUTE MYOCARDIAL-INFARCTION [J].

ARMSTRONG, PW ;

BAIGRIE, RS ;

DALY, PA ;

HAQ, A ;

GENT, M ;

ROBERTS, RS ;

FREEMAN, MR ;

BURNS, R ;

LIU, P ;

MORGAN, CD .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (07) :1469-1476

[5]

ATHERTON LA, 1989, J CRIT ILL S9, V4, P40

[6] MULTICENTER TRIAL OF INTRAVENOUS ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX (APSAC) IN ACUTE MYOCARDIAL-INFARCTION - EFFECTS ON INFARCT SIZE AND LEFT-VENTRICULAR FUNCTION [J].

BASSAND, JP ;

MACHECOURT, J ;

CASSAGNES, J ;

ANGUENOT, T ;

LUSSON, R ;

BOREL, E ;

PEYCELON, P ;

WOLF, E ;

DUCELLIER, D .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 13 (05) :988-997

[7] SAFETY AND TOLERANCE DATA FROM THE BELGIAN MULTICENTER STUDY OF ANISOYLATED PLASMINOGEN STREPTOKINASE ACTIVATOR COMPLEX VERSUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION [J].

BOSSAERT, LL .

DRUGS, 1987, 33 :287-292

[8]

BOUNAMEAUX H, 1992, THROMB HAEMOSTASIS, V67, P306

[9] HEMORRHAGIC EVENTS DURING THERAPY WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR, HEPARIN, AND ASPIRIN FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS OF THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI), PHASE-II TRIAL [J].

BOVILL, EG ;

TERRIN, ML ;

STUMP, DC ;

BERKE, AD ;

FREDERICK, M ;

COLLEN, D ;

FEIT, F ;

GORE, JM ;

HILLIS, LD ;

LAMBREW, CT ;

LEIBOFF, R ;

MANN, KG ;

MARKIS, JE ;

PRATT, CM ;

SHARKEY, SW ;

SOPKO, G ;

TRACY, RP ;

CHESEBRO, JH .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (04) :256-265

[10] HEMORRHAGIC COMPLICATIONS ASSOCIATED WITH THE USE OF INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR IN TREATMENT OF ACUTE MYOCARDIAL-INFARCTION [J].

CALIFF, RM ;

TOPOL, EJ ;

GEORGE, BS ;

BOSWICK, JM ;

ABBOTTSMITH, C ;

SIGMON, KN ;

CANDELA, R ;

MASEK, R ;

KEREIAKES, D ;

ONEILL, WW ;

STACK, RS ;

STUMP, D .

AMERICAN JOURNAL OF MEDICINE, 1988, 85 (03) :353-359

← 1 2 3 4 5 6 7 →